by Leanne Talbot | Oct 29, 2019
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth... by Leanne Talbot | Oct 17, 2019
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen. [npfButton... by Leanne Talbot | Oct 3, 2019
A fantastic INCA inspired article in Cancer World. Sophie Fessl hears from patients and experts about why specialist NET services are so important. Great work to all other contributors. [npfButton size=“small” text=”Click here to read the full... by Leanne Talbot | Sep 23, 2019
This autumn the International Neuroendocrine Cancer Alliance (INCA) invites NET patients and healthcare professionals to scan the access challenges to optimal care for NET patients. [npfButton size=“small” text=”Click here to find out more... by Leanne Talbot | Sep 19, 2019
It was great to see so many of you attending the Patient Education Event held Tuesday 3rd September in London. This event focused on Neuroendocrine Cancer research, the latest treatments and looking to the future – what’s next for NENs? Neuroendocrine... by Leanne Talbot | Sep 11, 2019
Join the NET Natter Oxford Team on 15 September 2019 for Oxford NET Natter’s Tripedathon, in aid of the NET Patient Foundation. ‘Our aim is to complete a ‘Tripedathon’ (a play on the traditional triathlon!) consisting of a sponsored walk, cycle and... 